Nuzenio

Drug Conjugate Program

Drug Conjugate Program news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G - BenzingaBenzinga · Thu, 06 Aug 2026 16:27:24 GMT VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb - The Manila TimesThe Manila Times · Mon, 27 Jul 2026 11:17:21 GMT VERAXA’s VXA-222 Uses One Molecule to Address Two Tumor Antigens - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT Veraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone - BioPharm InternationalBioPharm International · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 16:27:24 GMTVERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G - Benzinga

Mon, 27 Jul 2026 11:17:21 GMTVERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb - The Manila Times

Mon, 27 Jul 2026 07:00:00 GMTVERAXA’s VXA-222 Uses One Molecule to Address Two Tumor Antigens - Stock Titan

Mon, 27 Jul 2026 07:00:00 GMTVeraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone - BioPharm International

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

VXA4 live mentions NASDAQ2 live mentions VRXA2 live mentions Advances VXA2 live mentions Cancer Program While2 live mentions Expanding Patent Portfolio2 live mentions Next2 live mentions VERAXA Biotech Announces2 live mentions Advancement2 live mentions Novel Bispecific Antibody2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Drug Conjugate Program.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.